sr 33557 has been researched along with sphingosine in 1 studies
| Studies (sr 33557) | Trials (sr 33557) | Recent Studies (post-2010) (sr 33557) | Studies (sphingosine) | Trials (sphingosine) | Recent Studies (post-2010) (sphingosine) |
|---|---|---|---|---|---|
| 50 | 3 | 1 | 8,325 | 117 | 3,459 |
| Protein | Taxonomy | sr 33557 (IC50) | sphingosine (IC50) |
|---|---|---|---|
| ubiquitin-conjugating enzyme E2 N | Homo sapiens (human) | 6.3125 | |
| cAMP-dependent protein kinase catalytic subunit alpha | Rattus norvegicus (Norway rat) | 0.098 | |
| Sphingosine kinase 2 | Homo sapiens (human) | 1.56 | |
| Sphingosine kinase 1 | Homo sapiens (human) | 3.86 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chatelain, P; Gau, MN; Herbert, JM; Jaffrézou, JP; Laurent, G; Levade, T | 1 |
1 other study(ies) available for sr 33557 and sphingosine
| Article | Year |
|---|---|
Reversal of multidrug resistance by calcium channel blocker SR33557 without photoaffinity labeling of P-glycoprotein.
Topics: Animals; Calcium Channel Blockers; Drug Resistance; Indolizines; Leukemia, Experimental; Mice; Phenethylamines; Protein Kinase C; Second Messenger Systems; Sphingosine; Structure-Activity Relationship; Tumor Cells, Cultured; Verapamil | 1991 |